ATTR Amyloidosis: 1 in 4 Patients Experience Neurological and Cardiac Symptoms – Patient Worthy
Don’t miss this story about the latest ATTR amyloidosis research.
Don’t miss this story about the latest ATTR amyloidosis research.
Overview The 12th Annual Symposium on Global Cancer Research (ASGCR) will be held virtually May 6 – May 9, 2024 [8AM-12PM Eastern Time each day]. See…
What is deep vein thrombosis (DVT), and why are cancer patients more likely to develop it? General oncologist Ajit Bisen, M.D., shares his insights.
Núria Agustí Garcia, MD, discusses the mapping of sentinel lymph nodes in early-stage ovarian cancer.
An abstract is unavailable.
Zeynep Eroglu, MD, discusses how findings from a phase 1/2 study of ceritinib and trametinib could help inform future research in melanoma.
Sunday, May 5, 2024 7:50 AM to 8:00 AM · 10 min. (US/Central)
Kara N. Maxwell, MD, PhD, discusses the prevalence of germline mutations in racially diverse cohorts of patients with metastatic prostate cancer.
Frontline amivantamab with chemotherapy has been recommended for approval by the CHMP in EGFR exon 20 insertion+ non–small cell lung cancer.
CHMP has voiced its support for the approval of fruquintinib in previously treated metastatic colorectal cancer.
Gerard Walls, MB MRCP MSc FRCR, Queens University in Belfast, UK, discusses the NI-HEART analysis aimed at addressing the challenges of collecting cardiac toxicity events…